https://costcurve.beehiiv.com/ 2025-05-09 https://costcurve.beehiiv.com/subscribe 2025-05-09 https://costcurve.beehiiv.com/upgrade 2025-07-02 https://costcurve.beehiiv.com/authors 2026-04-06 https://costcurve.beehiiv.com/authors/brian-reid 2025-03-28 https://costcurve.beehiiv.com/forms/4ee2bf33-eb0f-4ddf-89f3-983bed08f03e 2023-05-30 https://costcurve.beehiiv.com/forms/98861be2-5ec9-44f9-ac0f-b8add0fa6135 2025-03-10 https://costcurve.beehiiv.com/p/can-lowcost-branded-medicine-succeed-theracosbio-find 2025-04-14 https://costcurve.beehiiv.com/p/charting-ira-lawsuits 2025-04-14 https://costcurve.beehiiv.com/p/going-deeper-on-another-pharm-to-conference-table-obesity-offering 2026-02-17 https://costcurve.beehiiv.com/p/pbm-reform-efforts-taking-baby-steps-direction-impact 2025-04-14 https://costcurve.beehiiv.com/p/looking-hood-pricing-approach-new-zepbound-obesity-med 2025-04-14 https://costcurve.beehiiv.com/p/two-ira-selected-drugs-face-off-leqembis-launch 2025-04-14 https://costcurve.beehiiv.com/p/earnings-bonanza-elevates-corporate-perspectives-iras-impacts 2025-04-14 https://costcurve.beehiiv.com/p/report-on-flovent-pricing-shows-how-a-law-designed-to-lower-list-prices-can-boomerang 2026-03-17 https://costcurve.beehiiv.com/p/senate-hearing-pharma-tomorrow-might-illuminate-theres-just-one-problem 2025-04-14 https://costcurve.beehiiv.com/p/new-lawsuit-suggests-employees-might-force-stops-markup-madness 2025-04-14 https://costcurve.beehiiv.com/p/patients-get-say-cms-pricesetting-process-heres-hoping-someone-listens 2025-04-14 https://costcurve.beehiiv.com/p/eyepopping-new-340b-numbers-drug-channels 2025-04-14 https://costcurve.beehiiv.com/p/turmoil-at-the-cdc-means-that-vaccine-access-is-already-being-impacted-in-a-real-way 2025-08-29 https://costcurve.beehiiv.com/p/the-calm-before-the-storm-links-on-340b-international-prices-and-obesity-while-we-wait-for-mfn-ira-a 2025-11-04 https://costcurve.beehiiv.com/p/trump-administration-official-offers-perspective-on-trumprx-the-goal-was-not-actually-some-massive-r 2026-03-20 https://costcurve.beehiiv.com/p/cbo-puts-thumb-scale-new-look-specialty-drug-prices 2025-04-14 https://costcurve.beehiiv.com/p/a-big-pbm-says-the-price-of-drugs-is-accelerating-but-other-industry-data-points-in-the-opposite-dir 2025-06-02 https://costcurve.beehiiv.com/p/handy-clipnsave-chart-ira-litigation 2025-04-14 https://costcurve.beehiiv.com/p/special-edition-the-minnesota-340b-report-is-out 2025-04-14 https://costcurve.beehiiv.com/p/colorado-considering-price-caps-enbrel-genvoya-cosentyx-stelara-trikafta 2025-04-14 https://costcurve.beehiiv.com/p/emd-serono-strikes-a-deal-offering-cheap-fertility-meds-to-trumprx-in-return-for-tariff-relief 2025-10-17 https://costcurve.beehiiv.com/p/cdc-data-costrelated-nonadherence-seniors-thinking-volvos 2025-04-14 https://costcurve.beehiiv.com/p/j-j-expands-its-legal-attack-on-alternative-funding-programs-to-include-a-pbm 2025-04-14 https://costcurve.beehiiv.com/p/the-search-for-clarity-on-the-differences-between-ira-and-mfn-prices-for-ozempic-and-wegovy 2025-12-01 https://costcurve.beehiiv.com/p/the-need-to-know-on-a-slow-news-day-more-mfn-deals-are-coming-and-why-pharma-thinks-the-u-s-u-k-trad 2025-12-03 https://costcurve.beehiiv.com/p/novo-slashes-list-prices-on-ozempic-and-wegovy-in-an-effort-to-improve-affordability-for-patients-wi 2026-02-24 https://costcurve.beehiiv.com/p/mark-cubanblue-shield-tieup-appears-bricks-not-clicks 2025-04-14 https://costcurve.beehiiv.com/p/when-will-cms-publish-the-next-set-of-negotiated-prices-for-medicare 2025-11-20 https://costcurve.beehiiv.com/p/the-quiet-trend-of-340b-clinics-and-hospitals-building-out-their-own-340b-pharmacies 2026-01-26 https://costcurve.beehiiv.com/p/the-push-for-a-fix-to-the-ira-pill-penalty-seems-to-be-turned-to-11 2025-03-03 https://costcurve.beehiiv.com/p/bloomberg-law-dove-deep-on-cms-explanations-for-negotiated-prices-and-found-them-hollow 2025-04-14 https://costcurve.beehiiv.com/p/new-campaign-unhelpfully-suggests-fight-pharma-sigh 2025-04-14 https://costcurve.beehiiv.com/p/orange-book-brouhaha-keeps-ignoring-elephant-room-fda 2025-04-14 https://costcurve.beehiiv.com/p/mercks-annual-pricing-transparency-report-dropped-says-merck-industry 2025-04-14 https://costcurve.beehiiv.com/p/mfn-conversations-have-started-pfizer-s-bourla-says-but-there-s-not-much-there-there-d205fea86c41a87 2025-06-10 https://costcurve.beehiiv.com/p/a-new-tracker-for-watching-meds-that-might-see-prices-slashed 2025-12-10 https://costcurve.beehiiv.com/p/north-carolina-strikes-a-deal-with-its-pbm-to-allow-the-state-to-negotiate-directly-for-obesity-meds 2025-10-16 https://costcurve.beehiiv.com/p/the-cbo-drops-numbers-on-what-the-reconciliation-bill-will-cost-and-save-with-insight-on-orphans-pbm 2025-05-21 https://costcurve.beehiiv.com/p/european-tariffs-as-expected-come-in-at-15-but-the-trade-deal-protects-against-even-bigger-levies-f0 2025-08-21 https://costcurve.beehiiv.com/p/using-profit-margins-to-attack-pharma-is-not-the-clear-win-that-pharma-skeptics-think-it-is 2025-04-14 https://costcurve.beehiiv.com/p/new-front-battle-tear-ira 2025-04-14 https://costcurve.beehiiv.com/p/a-plea-from-congress-to-providers-on-340b-transparency-if-i-can-t-see-it-i-can-t-help-you 2026-03-19 https://costcurve.beehiiv.com/p/im-sure-ive-written-headline-drug-prices-arent-skyrocketing 2025-04-14 https://costcurve.beehiiv.com/p/does-a-health-affairs-piece-on-inflation-penalties-in-the-private-market-come-too-late-to-matter 2025-03-04 https://costcurve.beehiiv.com/p/today-is-mostly-a-day-for-waiting 2025-11-25 https://costcurve.beehiiv.com/p/340b-used-to-be-too-dull-for-polite-company-this-week-s-news-coverage-suggests-that-s-changing 2025-03-19 https://costcurve.beehiiv.com/p/medicare-negotiated-prices-are-out-for-15-more-drugs-here-s-what-we-know 2025-11-26 https://costcurve.beehiiv.com/p/the-pharm-to-conference-table-trend-is-picking-up-steam 2025-11-21 https://costcurve.beehiiv.com/p/why-you-should-account-for-generics-when-thinking-about-u-s-prices-and-how-the-ira-will-raise-prices 2025-06-20 https://costcurve.beehiiv.com/p/is-a-new-trend-phony-pharm-to-table-emerging 2025-06-02 https://costcurve.beehiiv.com/p/new-regeneronhhs-deal-signal-new-approach-pricing-provisions 2025-04-14 https://costcurve.beehiiv.com/p/cms-is-about-to-announce-negotiated-prices-on-15-more-medicines-here-s-what-the-companies-involved-h 2025-11-13 https://costcurve.beehiiv.com/p/what-s-scarier-halloween-or-open-enrollment 2025-04-14 https://costcurve.beehiiv.com/p/blue-shield-deal-whomps-cvs-shares-pbms-still-game 2025-04-14 https://costcurve.beehiiv.com/p/forget-what-happened-last-week-pbm-reform-looks-very-much-alive-da545f5a86016586 2025-07-11 https://costcurve.beehiiv.com/p/emptiness-biden-ira-expansion-push 2025-04-14 https://costcurve.beehiiv.com/p/short-list-questions-wont-answered-tomorrows-senate-hearing 2025-04-14 https://costcurve.beehiiv.com/p/the-trump-mfn-eo-terrible-as-a-policy-prescription-but-solid-as-a-pr-stunt-768740d53ad293f6 2025-05-16 https://costcurve.beehiiv.com/p/thinking-one-iras-biggest-misses-orphan-drugs 2025-04-14 https://costcurve.beehiiv.com/p/the-prediction-markets-were-right-trump-mentions-trumprx-and-mfn-codification-in-his-lengthy-state-o 2026-02-25 https://costcurve.beehiiv.com/p/unitedhealths-pbm-made-1b-past-90-days 2025-04-14 https://costcurve.beehiiv.com/p/new-group-launches-fight-ftcs-meddling-biopharma-ma 2025-04-14 https://costcurve.beehiiv.com/p/sound-fury-orange-book-signifying-nothing 2025-04-14 https://costcurve.beehiiv.com/p/im-worried-will-widespread-inability-untangle-nearterm-longterm-ira-effects 2025-04-14 https://costcurve.beehiiv.com/p/americans-dont-want-government-go-around-breaking-patents-bayhdole-survey-finds 2025-04-14 https://costcurve.beehiiv.com/p/medicare-can-cover-obesity-meds-now-kind-will-coverage-look-like 2025-04-14 https://costcurve.beehiiv.com/p/the-many-twists-in-the-gordian-knot-that-is-obesity-med-coverage 2025-09-03 https://costcurve.beehiiv.com/p/nih-contributes-critical-drug-patents-new-analysis-finds 2025-04-14 https://costcurve.beehiiv.com/p/big-340b-day-starting-appeals-court-l-industry 2025-04-14 https://costcurve.beehiiv.com/p/astrazeneca-joins-pfizer-in-making-an-mfn-deal-with-trump 2025-10-15 https://costcurve.beehiiv.com/p/new-kaiser-survey-shows-outofcontrol-premiums-though-goodish-news 2025-04-14 https://costcurve.beehiiv.com/p/sanofi-s-transparency-report-highlights-the-continued-growth-of-rebates-paid-to-payers 2026-03-04 https://costcurve.beehiiv.com/p/medicaid-bestprice-rule-moment 2025-04-14 https://costcurve.beehiiv.com/p/az-announces-35-cap-inhalers-bigger-point-keeps-getting-missed 2025-04-14 https://costcurve.beehiiv.com/p/lilly-wins-fda-approval-for-its-foundayo-obesity-pill-which-will-cost-between-149-and-349 2026-04-01 https://costcurve.beehiiv.com/p/cms-costcontrol-lab-actually-increasing-health-spending-oof 2025-04-14 https://costcurve.beehiiv.com/p/survey-data-shows-employers-want-to-drive-the-pbm-conversation-toward-value-and-transparency 2025-04-14 https://costcurve.beehiiv.com/p/will-today-az-ira-lawsuit-decision-day 2025-04-14 https://costcurve.beehiiv.com/p/new-data-show-340b-works-really-well-patients-get-discounts 2025-04-14 https://costcurve.beehiiv.com/p/cms-explanations-for-maximum-fair-prices-feel-a-bit-like-coal-in-the-stocking 2025-04-14 https://costcurve.beehiiv.com/p/grab-bag-tuesday-cancer-drug-value-employers-and-benefit-design-and-some-m3p-news 2025-05-22 https://costcurve.beehiiv.com/p/rich-hospitals-using-340b-get-even-richer-according-new-analysis 2025-04-14 https://costcurve.beehiiv.com/p/the-four-most-interesting-comments-on-pbms-from-unitedhealth-s-earnings-call 2026-01-29 https://costcurve.beehiiv.com/p/what-the-heck-was-stat-driving-at-with-its-ham-handed-attempted-takedown-of-transparency-reports-83b 2025-08-04 https://costcurve.beehiiv.com/p/americans-difficulty-paying-health-care-thats-problem-everyone 2025-04-14 https://costcurve.beehiiv.com/p/kff-polling-confirms-no-one-knows-anything-ira 2025-04-14 https://costcurve.beehiiv.com/p/new-lawsuit-seeks-roll-back-dystopian-reality 2025-04-14 https://costcurve.beehiiv.com/p/a-decision-in-the-lawsuit-over-j-j-s-health-benefit-dents-maybe-one-avenue-to-pbm-reform 2025-04-14 https://costcurve.beehiiv.com/p/there-s-an-abbreviation-for-everyone-today-pbm-ira-340b-rfk-icer-nplb 2025-02-13 https://costcurve.beehiiv.com/p/how-mfn-raises-the-possibility-of-a-worst-of-both-worlds-approach-to-international-drug-pricing-c50d 2025-08-11 https://costcurve.beehiiv.com/p/medicare-benes-pay-33-cents-day-insulin-hhs-says-showing-access-important-price 2025-04-14 https://costcurve.beehiiv.com/p/new-york-times-puts-ira-a1 2025-04-14 https://costcurve.beehiiv.com/p/dont-need-open-newsletter 2025-04-14 https://costcurve.beehiiv.com/p/a-usc-analysis-tallies-the-potential-savings-associated-with-delinking-middleman-comp-from-list-pric 2025-07-25 https://costcurve.beehiiv.com/p/digging-into-paragon-s-policy-ideas-for-hints-about-where-trump-2-0-will-go-on-drug-pricing 2025-04-14 https://costcurve.beehiiv.com/p/chinese-obesity-med-break-open-us-market-probably-not-humor 2025-04-14 https://costcurve.beehiiv.com/p/cms-drops-pricecontrol-guidance-ruins-everyones-weekend 2025-04-14 https://costcurve.beehiiv.com/p/hear-something-new-ira-lawsuits-voice-judge 2025-04-14 https://costcurve.beehiiv.com/p/iqvias-global-rd-report-shows-rd-investments-getting-bigger-paying-off 2025-04-14 https://costcurve.beehiiv.com/p/bernie-got-lot-wrong-new-obesity-report-whole-lot 2025-04-14 https://costcurve.beehiiv.com/p/time-midyear-pricehike-silliness 2025-04-14 https://costcurve.beehiiv.com/p/trump-says-tariffs-are-coming-within-weeks-prompting-next-to-no-reaction-from-anyone-5fe35011d6546fc 2025-07-16 https://costcurve.beehiiv.com/p/new-post 2025-04-14 https://costcurve.beehiiv.com/p/all-eyes-are-on-mfn-but-action-and-specifics-remain-elusive-99a1bae041fe163b 2025-05-16 https://costcurve.beehiiv.com/p/will-pharma-s-mfn-deals-to-change-the-drug-price-reality-for-u-s-patients-or-european-governments 2026-01-08 https://costcurve.beehiiv.com/p/a-quick-curve-highlights-another-340b-lawsuit-and-near-term-prospects-for-pbm-reform 2025-04-14 https://costcurve.beehiiv.com/p/two-stories-glp1s-illustrate-weaponization-utilization-management 2025-04-14 https://costcurve.beehiiv.com/p/the-five-most-interesting-things-lilly-s-dave-ricks-said-on-the-cheeky-pint-pod 2025-11-18 https://costcurve.beehiiv.com/p/some-final-thoughts-from-jpm25-on-meeting-the-moment-and-hospital-finances 2025-04-14 https://costcurve.beehiiv.com/p/companies-have-a-unique-opportunity-to-seize-the-mfn-narrative-here-are-seven-ways-to-do-that-0 2025-05-29 https://costcurve.beehiiv.com/p/introducing-new-holiday-tradition-fight-club 2025-04-14 https://costcurve.beehiiv.com/p/no-one-had-dr-oz-on-their-bingo-card 2025-04-14 https://costcurve.beehiiv.com/p/payers-say-covid-and-flu-vaccine-reimbursements-will-remain-solid-regardless-of-cdc-changes 2025-09-18 https://costcurve.beehiiv.com/p/the-number-of-americans-skipping-scripts-jumped-between-2023-and-2025-kff-poll-finds 2026-03-13 https://costcurve.beehiiv.com/p/lillydirect-adds-neurology-to-its-pharm-to-table-platform 2025-06-02 https://costcurve.beehiiv.com/p/the-most-interesting-drug-pricing-news-of-the-year-is-flying-under-the-radar 2026-01-06 https://costcurve.beehiiv.com/p/breaking-news-on-mfn-targets-and-a-review-of-the-right-s-reaction-to-the-policy-b849a939288b45d1 2025-05-20 https://costcurve.beehiiv.com/p/united-made-piles-of-money-last-quarter-but-slowing-growth-set-off-alarm-bells 2025-04-17 https://costcurve.beehiiv.com/p/the-announcement-prices-in-medicare-are-coming-soon-with-earnings-calls-offering-a-glimpse-into-nego 2025-11-03 https://costcurve.beehiiv.com/p/cms-proposes-new-rules-will-implement-ira 2025-04-14 https://costcurve.beehiiv.com/p/novo-s-latest-pharm-to-table-deals-show-how-the-trend-is-evolving-into-an-ecosystem-17bfaadac88 2025-08-28 https://costcurve.beehiiv.com/p/advice-on-how-to-think-about-a-system-heading-over-a-cliff 2025-04-14 https://costcurve.beehiiv.com/p/pbmbranded-stelara-biosimilar-make-interesting-jan-1-2026 2025-04-14 https://costcurve.beehiiv.com/p/international-reference-pricing-is-back-on-the-agenda-expect-headaches-to-ensue 2025-03-21 https://costcurve.beehiiv.com/p/the-government-has-green-lit-a-major-change-to-340b-payments-with-some-limits-96fdd172706236e7 2025-08-01 https://costcurve.beehiiv.com/p/ira-reactions-jnj-novartis-earnings-calls-underscore-longterm-ira-impacts 2025-04-14 https://costcurve.beehiiv.com/p/the-340b-content-keeps-coming-covered-entities-respond-to-the-hrsa-numbers-a-worthwhile-poll-and-mor 2025-04-14 https://costcurve.beehiiv.com/p/looking-at-the-ever-morphing-report-that-pbms-are-using-in-their-anti-ftc-lawsuit 2025-04-14 https://costcurve.beehiiv.com/p/appeals-court-rejects-astrazeneca-s-ira-suit-including-the-definition-of-drug-element-7d9e6a37623239 2025-05-16 https://costcurve.beehiiv.com/p/trumprx-continues-to-drive-pricing-chatter-with-attention-on-generics-and-goodrx 2026-02-09 https://costcurve.beehiiv.com/p/new-analysis-associates-340b-30b-annual-costs-medicaid 2025-04-14 https://costcurve.beehiiv.com/p/happy-first-birthday-cost-curve 2025-04-14 https://costcurve.beehiiv.com/p/bernie-sanders-wants-talk-ceos-us-vs-row-pricing-bring-say 2025-04-14 https://costcurve.beehiiv.com/p/more-thinking-around-the-two-big-stories-of-the-moment-340b-numbers-and-pbms-killing-pharmacy 2025-04-14 https://costcurve.beehiiv.com/p/the-wait-for-340b-rebate-model-guidance-from-the-government-just-got-longer-13d1923350bfec9a 2025-06-03 https://costcurve.beehiiv.com/p/cms-releases-the-final-rules-for-the-next-set-of-price-controls-including-updates-on-how-it-ll-gathe 2025-04-14 https://costcurve.beehiiv.com/p/why-one-small-company-about-to-take-on-an-industry-giant-won-t-compete-on-price 2026-01-13 https://costcurve.beehiiv.com/p/looking-at-the-pioneers-in-the-nacent-pharm-to-table-movement 2025-03-11 https://costcurve.beehiiv.com/p/pouring-one-eqrx 2025-04-14 https://costcurve.beehiiv.com/p/breast-cancer-death-rate-way-way-theres-lesson 2025-04-14 https://costcurve.beehiiv.com/p/mustread-bloomberg-piece-gene-therapy-highlights-biggest-dilemma-pharma 2025-04-14 https://costcurve.beehiiv.com/p/harvard-portal-approach-everything-everywhere 2025-04-14 https://costcurve.beehiiv.com/p/legal-battle-ira-begins 2025-04-14 https://costcurve.beehiiv.com/p/will-ira-delay-market-entry-cancer-drugs-nejm-says-no-im-not-sure-buy 2025-04-14 https://costcurve.beehiiv.com/p/latest-adam-fein-weird-ira-incentives-might-backfire-patients 2025-04-14 https://costcurve.beehiiv.com/p/evidence-drugs-arent-driving-us-health-spending 2025-04-14 https://costcurve.beehiiv.com/p/things-mind-await-ira-price-control-announcement 2025-04-14 https://costcurve.beehiiv.com/p/the-government-offers-its-most-detailed-description-yet-of-how-to-calculate-a-most-favored-nation-pr 2025-11-11 https://costcurve.beehiiv.com/p/gallup-s-industry-favorability-ratings-are-out-and-pharma-doesn-t-look-so-good 2025-04-14 https://costcurve.beehiiv.com/p/three-ways-of-looking-at-yesterday-s-cigna-express-scripts-announcement-on-rebates 2025-10-28 https://costcurve.beehiiv.com/p/bernie-sanders-thinking-old-super-bowl-ad 2025-04-14 https://costcurve.beehiiv.com/p/bernie-will-get-ceos-capitol-hill-nc-will-not-get-obesity-meds-beneficiaries 2025-04-14 https://costcurve.beehiiv.com/p/valuing-obesity-drugs-isnt-clever-depressing-jpm24-thoughts 2025-04-14 https://costcurve.beehiiv.com/p/with-mfn-deals-in-the-rear-view-mirror-pharma-ceos-at-jpm-say-they-can-focus-more-on-the-fundamental 2026-01-14 https://costcurve.beehiiv.com/p/some-personal-news-i-m-going-to-start-working-with-tufts-cevr 2025-04-14 https://costcurve.beehiiv.com/p/reimbursement-for-hep-b-shots-should-remain-stable-even-as-cdc-panel-undermines-the-vaccine 2025-12-08 https://costcurve.beehiiv.com/p/j-j-quantifies-the-impact-of-its-mfn-concessions-it-s-hundreds-of-millions-of-dollars 2026-01-21 https://costcurve.beehiiv.com/p/gsk-says-medicare-negotiations-are-complete-and-in-line-with-expectations 2025-10-30 https://costcurve.beehiiv.com/p/groundhogs-day-another-analysis-shows-340b-dollars-arent-translating-charity-care 2025-04-14 https://costcurve.beehiiv.com/p/two-ways-thinking-new-ftc-report-pbms 2025-04-14 https://costcurve.beehiiv.com/p/how-companies-with-pharm-to-table-programs-are-addressing-medicare-anti-kickback-concerns 2026-02-02 https://costcurve.beehiiv.com/p/new-jama-research-shows-how-much-and-how-rapidly-part-d-plans-have-shifted-drug-costs-to-consumers 2025-02-17 https://costcurve.beehiiv.com/p/virus-knocked-loop-im-playing-catch 2025-04-14 https://costcurve.beehiiv.com/p/blue-shield-ca-embarking-grand-experiment-around-worth-pbms 2025-04-14 https://costcurve.beehiiv.com/p/gearing-up-for-the-battle-and-the-battles-to-come-over-innovation 2025-04-14 https://costcurve.beehiiv.com/p/celebrating-a-new-schizophrenia-drug-and-hoping-the-value-it-delivers-is-recognized 2025-04-14 https://costcurve.beehiiv.com/p/marchin-rights-isnt 2025-04-14 https://costcurve.beehiiv.com/p/sanofi-s-pricing-transparency-effort-brings-sunlight-to-340b-growth-and-pbm-fees 2025-03-05 https://costcurve.beehiiv.com/p/cigna-details-the-costs-of-moving-its-pbm-away-from-rebates-freaking-out-wall-street 2025-10-31 https://costcurve.beehiiv.com/p/a-bigger-better-future-is-coming-for-cost-curve 2025-06-02 https://costcurve.beehiiv.com/p/novo-and-telehealth-companies-team-up-in-the-next-turn-of-the-pharm-to-table-story 2025-05-20 https://costcurve.beehiiv.com/p/the-uk-is-suddenly-a-flashpoint-in-the-battle-over-price-and-access-4eb058e4e67ad48d 2025-08-26 https://costcurve.beehiiv.com/p/american-health-care-the-best-system-that-4-9-trillion-can-buy 2025-04-14 https://costcurve.beehiiv.com/p/off-day-curve-couple-links-anyway 2025-04-14 https://costcurve.beehiiv.com/p/trying-get-curve-sun-sets 2025-04-14 https://costcurve.beehiiv.com/p/three-new-drugs-three-prices-three-disclosure-approaches-b831fe3476f97623 2025-08-13 https://costcurve.beehiiv.com/p/colorados-pdab-finds-another-drug-unaffordable-per-somewhat-inscrutable-standards 2025-04-14 https://costcurve.beehiiv.com/p/even-more-on-medicare-and-obesity-newspapers-are-editorializing-execs-are-explaining 2025-11-10 https://costcurve.beehiiv.com/p/drugmakers-aren-t-buying-what-the-white-house-is-selling-on-mfn 2026-03-31 https://costcurve.beehiiv.com/p/companies-and-nations-respond-to-the-u-s-u-k-agreement-to-eliminate-tariffs-boost-drug-prices 2025-12-04 https://costcurve.beehiiv.com/p/poll-shows-docs-probably-rest-us-use-340b-education 2025-04-14 https://costcurve.beehiiv.com/p/the-average-premium-for-a-family-with-commercial-insurance-is-now-27-000-is-that-sustainable 2025-10-22 https://costcurve.beehiiv.com/p/medicare-negotiations-are-over-here-s-what-to-read-while-you-wait-for-the-final-prices 2025-10-20 https://costcurve.beehiiv.com/p/quick-look-everything-missed-gone 2025-04-14 https://costcurve.beehiiv.com/p/judge-rules-phrma-ira-case-matter 2025-04-14 https://costcurve.beehiiv.com/p/there-s-a-ton-of-trump-coverage-i-m-just-not-sure-you-need-to-pay-close-attention 2025-04-14 https://costcurve.beehiiv.com/p/why-ira-negotiations-and-mfn-dealmaking-led-to-such-different-prices-for-ozempic-and-wegovy 2025-12-09 https://costcurve.beehiiv.com/p/senate-report-on-340b-rams-home-a-simple-message-the-program-is-broken 2025-05-20 https://costcurve.beehiiv.com/p/pushing-back-pricecontrol-arguments-fervor-list-fades 2025-04-14 https://costcurve.beehiiv.com/p/at-the-risk-of-repetition-it-was-another-quarter-of-record-profits-for-united-s-pbm-unit 2025-04-14 https://costcurve.beehiiv.com/p/drugs-from-europe-will-be-hit-with-a-15-tariff-but-key-details-are-still-cloudy-672ebeaffc5799a6 2025-07-29 https://costcurve.beehiiv.com/p/strong-data-showing-heart-benefits-obesity-meds-raises-big-question-whither-medicare 2025-04-14 https://costcurve.beehiiv.com/p/another-lawsuit-another-flashing-warning-light-employers-botch-pbm-decisionmaking 2025-04-14 https://costcurve.beehiiv.com/p/how-quickly-do-pharma-companies-update-the-prices-on-drug-websites 2026-01-20 https://costcurve.beehiiv.com/p/viral-exchange-hill-hearing-makes-clear-stakes-around-ira-communications 2025-04-14 https://costcurve.beehiiv.com/p/j-p-morgan-is-getting-sued-by-its-employees-for-overpaying-for-generic-drugs 2025-03-14 https://costcurve.beehiiv.com/p/pbm-reactions-nyt-takedown-revealing 2025-04-14 https://costcurve.beehiiv.com/p/today-is-the-biggest-day-ever-for-pbm-news-no 2025-04-14 https://costcurve.beehiiv.com/p/the-government-and-companies-are-both-preparing-for-the-as-yet-unannounced-pharma-tariffs-6e109b89ce 2025-05-23 https://costcurve.beehiiv.com/p/cigna-express-scripts-unveils-a-plan-to-move-away-from-rebates 2025-10-28 https://costcurve.beehiiv.com/p/six-policy-questions-that-j-p-morgan-presentations-may-help-answer 2026-01-12 https://costcurve.beehiiv.com/p/even-jpm24-kicks-off-sf-pricing-conversation-remains-centered-dc 2025-04-14 https://costcurve.beehiiv.com/p/the-threat-of-medicare-putting-on-fiscal-weight-torpedoes-coverage-of-obesity-meds 2025-04-07 https://costcurve.beehiiv.com/p/trump-says-pharma-tariffs-may-be-pushed-back-but-could-be-enormous-if-when-they-do-arrive-3ccc53c72d 2025-07-09 https://costcurve.beehiiv.com/p/earnings-season-kicks-off-tomorrow-change-healthcare-wont-story 2025-04-14 https://costcurve.beehiiv.com/p/another-dozen-thoughts-cms-selected-drug-list 2025-04-14 https://costcurve.beehiiv.com/p/reading-on-340b-while-waiting-on-340b-8bd47e757b3c7559 2025-06-02 https://costcurve.beehiiv.com/p/four-takeaways-from-minnesota-s-340b-transparency-report 2026-03-02 https://costcurve.beehiiv.com/p/pbm-industry-new-trick-rebate-credit 2025-04-14 https://costcurve.beehiiv.com/p/big-pharma-companies-won-concessions-via-dealmaking-with-trump-but-what-happens-to-everyone-else-ad9 2026-02-12 https://costcurve.beehiiv.com/p/the-tax-relief-and-medicaid-cuts-bill-nears-the-finish-line-with-four-big-implications-for-the-pharm 2025-07-03 https://costcurve.beehiiv.com/p/nine-thoughts-on-rfk-jr-s-nomination-to-head-hhs 2025-04-14 https://costcurve.beehiiv.com/p/pbms-are-all-over-the-place-today-on-the-hill-in-the-media-at-the-courthouse 2025-02-26 https://costcurve.beehiiv.com/p/glp-1s-are-out-of-shortage-putting-compounders-on-very-thin-ice-all-of-sudden 2025-02-24 https://costcurve.beehiiv.com/p/scotus-strikes-chevron-lots-fdacmshhs-regs-may-soon-legal-crosshairs 2025-04-14 https://costcurve.beehiiv.com/p/couple-worthwhile-pieces-read-watch-senate-hearing 2025-04-14 https://costcurve.beehiiv.com/p/please-celebrate-festivus-with-cost-curve-by-airing-your-grievances 2025-12-17 https://costcurve.beehiiv.com/p/j-j-becomes-company-no-15-to-make-a-deal-with-the-white-house-though-details-remain-sparse 2026-01-09 https://costcurve.beehiiv.com/p/whats-important-enough-prompt-senators-work-week-copay-accumulators-natch 2025-04-14 https://costcurve.beehiiv.com/p/new-kff-polling-suggests-people-still-not-lot-people-tracking-ira 2025-04-14 https://costcurve.beehiiv.com/p/bernies-pushing-get-novo-testify-obesity-prices-waste 2025-04-14 https://costcurve.beehiiv.com/p/a-smart-tufts-cevr-look-at-every-the-cost-effectiveness-analysis-published-for-the-meds-cms-is-curre 2025-09-16 https://costcurve.beehiiv.com/p/new-high-estimate-drugdevelopment-costs-unlikely-quarter 2025-04-14 https://costcurve.beehiiv.com/p/cms-names-the-next-15-meds-due-for-negotiation 2026-01-28 https://costcurve.beehiiv.com/p/new-jama-paper-patent-law-good-excuse-detail-arnold-playbook 2025-04-14 https://costcurve.beehiiv.com/p/grab-bag-today-2024-price-hikes-340b-orange-book-smoothing 2025-04-14 https://costcurve.beehiiv.com/p/phrma-unveils-a-three-point-plan-to-address-trump-concerns-about-drug-prices-and-manufacturing 2025-09-29 https://costcurve.beehiiv.com/p/nyt-explains-net-prices-slim-obesity-spending-conversation 2025-04-14 https://costcurve.beehiiv.com/p/ira-selected-drugs-340b-come-big-first-round-fight-club 2025-04-14 https://costcurve.beehiiv.com/p/what-state-and-local-governments-can-teach-us-about-understanding-of-340b 2025-04-14 https://costcurve.beehiiv.com/p/ira-340b-leqembi-house-pbm-reform-advance-fight-club-final-four 2025-04-14 https://costcurve.beehiiv.com/p/the-evolution-of-roche-s-pharma-day-approach-to-talking-pricing-and-value 2025-04-14 https://costcurve.beehiiv.com/p/industry-details-objections-icers-approach 2025-04-14 https://costcurve.beehiiv.com/p/new-post-8512 2025-04-14 https://costcurve.beehiiv.com/p/lilly-and-novo-are-reportedly-near-a-deal-offering-149-glp-1s-in-return-for-coverage-in-medicare 2025-11-05 https://costcurve.beehiiv.com/p/trying-to-nail-the-cost-effectiveness-of-obesity-meds-is-a-moving-target-but-folks-are-nonetheless-t 2025-03-18 https://costcurve.beehiiv.com/p/cms-trying-minimize-visibility-patient-input-price-controls 2025-04-14 https://costcurve.beehiiv.com/p/the-government-is-looking-for-340b-rebate-model-feedback-as-it-resurrects-rulemaking 2026-02-13 https://costcurve.beehiiv.com/p/marchin-rights-conversation-lot-common-pro-wrestling 2025-04-14 https://costcurve.beehiiv.com/p/the-universe-of-direct-to-business-obesity-options-continues-to-expand 2025-11-24 https://costcurve.beehiiv.com/p/cowardly-compromise-medicare-obesity-coverage-gets-house-committee-vote 2025-04-14 https://costcurve.beehiiv.com/p/reaction-new-piece-price-hikes-shows-cant-nice-things 2025-04-14 https://costcurve.beehiiv.com/p/reuters-analysis-gets-right-wrong-2023-launch-prices 2025-04-14 https://costcurve.beehiiv.com/p/pricing-transparency-today-ucb-2023-numbers-show-recordhigh-discounts 2025-04-14 https://costcurve.beehiiv.com/p/the-wsj-just-ran-a-story-showing-how-the-lack-of-340b-oversight-is-opening-the-door-to-abuse 2025-03-17 https://costcurve.beehiiv.com/p/cbo-data-shows-340b-tale-two-providers 2025-04-14 https://costcurve.beehiiv.com/p/bold-predictions-next-15-meds-face-ira-price-controls 2025-04-14 https://costcurve.beehiiv.com/p/introducing-the-trumprx-tracker 2026-03-24 https://costcurve.beehiiv.com/p/two-ways-think-biden-administrations-move-patent-rights 2025-04-14 https://costcurve.beehiiv.com/p/starting-gun-price-controls-will-sound-tomorrow-finish-line-still-year-away 2025-04-14 https://costcurve.beehiiv.com/p/quick-hits-today-eu-pharma-rules-accumulators-cuban-tweets 2025-04-14 https://costcurve.beehiiv.com/p/fifteen-more-drugs-will-get-price-controls-next-month-here-s-how-to-prepare 2025-10-06 https://costcurve.beehiiv.com/p/more-evidence-that-340b-is-siphoning-billions-from-the-government-0d528fe68f703812 2025-07-15 https://costcurve.beehiiv.com/p/more-340b-math-showing-that-the-drug-discount-program-is-getting-unimaginingly-large 2025-04-14 https://costcurve.beehiiv.com/p/here-s-the-math-behind-the-idea-that-ira-negotiations-will-kill-early-stage-programs 2025-06-02 https://costcurve.beehiiv.com/p/lot-heart-disease-innovation-happens-approval-will-ira-kill 2025-04-14 https://costcurve.beehiiv.com/p/more-evidence-that-the-ira-s-warped-incentives-are-reducing-research 2025-04-23 https://costcurve.beehiiv.com/p/looking-guess-will-cms-announce-ira-prices 2025-04-14 https://costcurve.beehiiv.com/p/not-talk-costs-benefits-obesity-drugs 2025-04-14 https://costcurve.beehiiv.com/p/the-obesity-pricing-paradigm-gets-even-more-complex-with-novo-s-199-wegovy-offer 2025-11-17 https://costcurve.beehiiv.com/p/bernie-demands-drugpricing-plan 2025-04-14 https://costcurve.beehiiv.com/p/gsk-s-price-transparency-data-is-out-net-prices-are-falling 2026-03-09 https://costcurve.beehiiv.com/p/astrazeneca-loses-ira-legal-battle-making-progress-war-around-rare-disease 2025-04-14 https://costcurve.beehiiv.com/p/big-companies-are-far-less-likely-to-disclose-drug-prices-than-smaller-ones-new-study-shows 2025-12-15 https://costcurve.beehiiv.com/p/pseudo-pharmas-are-getting-bigger-and-getting-creative-when-it-comes-to-pricing-34116623e68dcdff 2025-07-23 https://costcurve.beehiiv.com/p/i-want-your-thoughts-what-2025-advice-do-you-have-for-curve-readers 2025-04-14 https://costcurve.beehiiv.com/p/latebreaking-news-phrma-sues-ira-means-late-curve 2025-04-14 https://costcurve.beehiiv.com/p/dissecting-pbm-response-last-weeks-broadside-ftc 2025-04-14 https://costcurve.beehiiv.com/p/it-s-formulary-season-and-early-analyses-suggest-big-changes-in-how-pbms-approach-biosims 2025-09-22 https://costcurve.beehiiv.com/p/apex-a-new-reuters-analysis-of-2024-launch-prices-doesn-t-say-what-reuters-thinks-it-does-b312d44120 2025-05-23 https://costcurve.beehiiv.com/p/pushing-international-prices-into-medicaid-comes-with-a-1-000-000-000-000-price-tag-9bd90c400a6ebeda 2025-05-16 https://costcurve.beehiiv.com/p/florida-gets-fda-goahead-try-import-drugs-abroad-emphasis-try 2025-04-14 https://costcurve.beehiiv.com/p/new-postboth-novo-wapo-define-obesitymed-challenge-well-defining-solutions-another-matter 2025-04-14 https://costcurve.beehiiv.com/p/oversight-of-340b-as-measured-by-audits-audit-findings-is-woefully-lagging-new-analysis-finds-9c0610 2025-06-23 https://costcurve.beehiiv.com/p/still-talking-obesity-today 2025-04-14 https://costcurve.beehiiv.com/p/pharmacists-say-the-rollout-of-negotiated-prices-in-medicare-is-leading-to-a-cash-flow-crunch 2026-03-03 https://costcurve.beehiiv.com/p/a-new-lawsuit-crystallizes-the-abuses-and-lack-of-oversight-in-340b 2025-04-14 https://costcurve.beehiiv.com/p/tyson-foods-ditches-megapbm-favor-upstart-really-get-partner 2025-04-14 https://costcurve.beehiiv.com/p/cms-plans-to-keep-payments-to-medicare-advantage-insurers-flat-next-year-devastating-payer-share-pri 2026-01-27 https://costcurve.beehiiv.com/p/moving-to-mfn-means-qalys-long-rejected-by-u-s-policymakers-as-discriminatory-would-be-used-to-set-p 2026-02-19 https://costcurve.beehiiv.com/p/the-administration-continues-to-make-headlines-but-not-policy-on-pharma-issues-ebabcd681453553f 2025-06-18 https://costcurve.beehiiv.com/p/at-the-core-of-the-latest-pharm-to-table-dispute-which-glp-1-was-hims-preferring-1caf4a765e6d9e7b 2025-06-24 https://costcurve.beehiiv.com/p/340b-can-be-hard-to-parse-especially-for-ai 2025-05-22 https://costcurve.beehiiv.com/p/if-all-340b-content-is-good-340b-content-then-i-have-great-news 2025-04-14 https://costcurve.beehiiv.com/p/tariffs-are-illegal-maybe-but-that-might-not-matter-for-meds 2025-09-02 https://costcurve.beehiiv.com/p/hoo-boy-what-a-day-an-ftc-pbm-report-nyt-goes-deep-on-340b-jpm25-stuff-and-more 2025-04-14 https://costcurve.beehiiv.com/p/circumstantial-evidence-ira-affecting-development-piling 2025-04-14 https://costcurve.beehiiv.com/p/novartis-roche-abbvie-reportedly-on-deck-for-white-house-mfn-announcements-tomorrow 2025-12-18 https://costcurve.beehiiv.com/p/almost-no-one-prescribed-obesity-meds-2012-2019-actually-filled-scrip 2025-04-14 https://costcurve.beehiiv.com/p/sarepta-prices-gene-therapy-32m-brings-receipts 2025-04-14 https://costcurve.beehiiv.com/p/bausch-pulls-its-meds-from-medicaid-and-340b 2025-10-09 https://costcurve.beehiiv.com/p/a-new-health-affairs-forefront-piece-seeks-to-reset-the-pharm-to-table-conversation 2025-12-05 https://costcurve.beehiiv.com/p/j-j-puts-its-340b-rebate-efforts-on-ice-but-we-re-not-remotely-done-here 2025-04-14 https://costcurve.beehiiv.com/p/yesterday-brought-two-new-drug-approvals-and-two-pricing-announcements 2026-03-26 https://costcurve.beehiiv.com/p/apex-special-edition-all-things-ira-9ce865860f21a3f9 2025-06-06 https://costcurve.beehiiv.com/p/jama-pushes-effort-strengthen-ftc-eyeroll-emoji-goes 2025-04-14 https://costcurve.beehiiv.com/p/a-blizzard-of-quick-hits-to-get-you-to-the-weekend 2025-02-22 https://costcurve.beehiiv.com/p/the-pbms-are-trying-to-sell-cms-on-a-splashy-announcement-that-they-will-voluntarily-do-the-right-th 2025-09-25 https://costcurve.beehiiv.com/p/the-government-could-upend-340b-next-week-here-are-three-ways-that-could-go-down-4e1d1789faf2f33a 2025-05-30 https://costcurve.beehiiv.com/p/amazon-knits-safety-net-around-insulin-little-tighter 2025-04-14 https://costcurve.beehiiv.com/p/witty-says-unitedhealth-doesnt-drug-companies-not-yet-anyway 2025-04-14 https://costcurve.beehiiv.com/p/patient-feedback-cms-ira-please-please-keep-access-mind 2025-04-14 https://costcurve.beehiiv.com/p/unitedhealth-broke-us-health-care-system-boffo-earnings-anyway 2025-04-14 https://costcurve.beehiiv.com/p/lilly-launches-lillydirect-delivering-telehealth-pharmacy-solutions-zepbound 2025-04-14 https://costcurve.beehiiv.com/p/cms-negotiations-on-ozempic-s-price-will-be-a-big-deal-but-stay-skeptical-on-predictions 2025-04-14 https://costcurve.beehiiv.com/p/340b-remains-in-the-spotlight-with-new-legislation-court-battles-and-the-pending-rebate-model-launch 2025-09-11 https://costcurve.beehiiv.com/p/the-five-topics-in-health-care-with-the-highest-importance-to-attention-ratio 2025-03-13 https://costcurve.beehiiv.com/p/three-takeaways-white-house-listening-session-pbms 2025-04-14 https://costcurve.beehiiv.com/p/theres-lot-unpack-today-starting-political-theater-bernie-biden 2025-04-14 https://costcurve.beehiiv.com/p/two-ways-of-thinking-about-the-first-day-of-jpm25 2025-04-14 https://costcurve.beehiiv.com/p/trump-s-plan-for-mfn-largely-wishful-thinking-with-thin-gruel-for-policy-wonks-e73b5a30575e7502 2025-05-16 https://costcurve.beehiiv.com/p/new-research-underscores-positive-impact-accelerated-approval 2025-04-14 https://costcurve.beehiiv.com/p/pbm-week-continues-news-pending-lawsuits-congressional-hearings 2025-04-14 https://costcurve.beehiiv.com/p/ira-negotiations-begin-judges-weigh-novo-sues-icer-drop-white-paper 2025-04-14 https://costcurve.beehiiv.com/p/senate-letter-insulin-offers-opportunity-set-record-straight-assistance 2025-04-14 https://costcurve.beehiiv.com/p/americans-love-the-idea-of-a-website-that-offers-cash-pay-discounts-but-they-like-it-less-when-it-s 2026-02-20 https://costcurve.beehiiv.com/p/rfk-jr-takes-aim-at-the-preventive-services-task-force-injecting-more-uncertainty-into-public-health 2025-07-28 https://costcurve.beehiiv.com/p/cbo-raises-cost-estimate-of-the-orphan-provisions-of-the-tax-and-medicaid-cuts-bill 2025-10-21 https://costcurve.beehiiv.com/p/becerras-cluelessness-accumulators-underscores-administrations-meh-approach-pbms 2025-04-14 https://costcurve.beehiiv.com/p/a-big-study-found-that-semaglutide-users-saw-increased-health-spending-should-we-be-surprised-e50e63 2025-08-12 https://costcurve.beehiiv.com/p/with-the-pfizer-trumprx-announcement-in-the-rearview-mirror-here-are-some-questions-that-remain 2025-10-02 https://costcurve.beehiiv.com/p/health-affairs-paper-shows-high-rate-of-pharmacy-closures-in-exactly-the-places-they-re-needed-most 2025-04-14 https://costcurve.beehiiv.com/p/thinking-drugpricing-way-compelling-simple-wrong 2025-04-14 https://costcurve.beehiiv.com/p/hardly-anyone-is-using-the-medicare-prescription-payment-plan-96d245bcc2123d81 2025-08-18 https://costcurve.beehiiv.com/p/nailbiting-house-vote-coming-today-pbms 2025-04-14 https://costcurve.beehiiv.com/p/the-2028-ira-negotiations-are-going-to-be-brutal-for-docs-oncologists-warn-f78cfdd48bee7f73 2025-06-27 https://costcurve.beehiiv.com/p/clearing-the-decks-walgreens-get-sold-makary-on-drug-prices-and-the-economic-impact-of-clinical-tria 2025-03-07 https://costcurve.beehiiv.com/p/pfizer-goes-deep-on-the-hows-and-whys-of-the-1-billion-part-d-redesign-impact 2025-06-02 https://costcurve.beehiiv.com/p/a-new-antibiotic-might-make-for-the-most-interesting-pricing-story-of-the-year 2025-09-24 https://costcurve.beehiiv.com/p/sanders-novo-faceoff-resurrects-a-strawman-the-idea-that-price-and-r-d-spend-are-connected 2025-04-14 https://costcurve.beehiiv.com/p/three-worthwhile-nuggets-interview-head-pbm-lobby 2025-04-14 https://costcurve.beehiiv.com/p/ira-lawsuits-coming-phrma-chief-predicts 2025-04-14 https://costcurve.beehiiv.com/p/the-obesity-conversation-can-t-just-ignore-that-glp-1s-are-cost-effective 2025-05-22 https://costcurve.beehiiv.com/p/slow-week-reasons-thats-likely-change 2025-04-14 https://costcurve.beehiiv.com/p/health-insurance-us-broken-like-really-broken 2025-04-14 https://costcurve.beehiiv.com/p/j-j-publishes-its-annual-transparency-report-discloses-that-it-gave-back-58-of-revenue-in-rebates-di 2025-07-22 https://costcurve.beehiiv.com/p/earnings-szn-bit-bust-far-pricing-policy-perspectives 2025-04-15 https://costcurve.beehiiv.com/p/lilly-joins-sanofi-s-legal-fight-to-get-hrsa-to-open-up-about-how-340b-really-works 2025-04-15 https://costcurve.beehiiv.com/p/so-many-research-papers-to-dissect-today 2025-04-15 https://costcurve.beehiiv.com/p/copay-accumulators-terrible-concept-thats-still-picking-steam 2025-04-15 https://costcurve.beehiiv.com/p/the-ftc-vs-pbm-slugfest-continues-as-the-government-sues-the-middlemen-over-insulin-rebates 2025-04-15 https://costcurve.beehiiv.com/p/a-section-by-section-breakdown-of-the-pbm-provisions-in-the-big-year-end-spending-bill 2025-04-15 https://costcurve.beehiiv.com/p/colorado-victory-patients-declares-trikafta-not-unaffordable 2025-04-15 https://costcurve.beehiiv.com/p/virginia-lovers-not-pdabs 2025-04-15 https://costcurve.beehiiv.com/p/pfizer-s-pricing-transparency-disclosures-are-out-the-company-s-net-prices-fell-2-last-year-9562e665 2025-06-04 https://costcurve.beehiiv.com/p/thoughts-on-an-arnold-ventures-backed-poll-on-negotiations-that-fails-to-account-for-access-innovati 2025-05-20 https://costcurve.beehiiv.com/p/a-huge-number-of-employers-are-clueless-about-where-their-pbm-rebates-go 2025-04-15 https://costcurve.beehiiv.com/p/eyeopening-asco-study-suggests-costs-falling-many-cancers 2025-04-15 https://costcurve.beehiiv.com/p/the-complexity-of-covid-vaccine-regulation-is-hampering-patient-access 2025-09-08 https://costcurve.beehiiv.com/p/nih-cuts-would-mean-dozens-of-new-drugs-could-be-lost-per-a-cbo-analysis-that-likely-understates-the 2025-07-21 https://costcurve.beehiiv.com/p/humira-maintaining-mammoth-market-share-expect-hear 2025-04-15 https://costcurve.beehiiv.com/p/it-s-deadline-day-trump-s-first-drug-related-executive-order-calls-for-action-on-middlemen-and-impor 2025-07-14 https://costcurve.beehiiv.com/p/bernie-sanders-still-not-constructive-obesity-pricing 2025-04-15 https://costcurve.beehiiv.com/p/roche-is-considering-pharm-to-table-as-a-weapon-to-use-against-middlemen-ed46cfb94c3cbe4f 2025-07-24 https://costcurve.beehiiv.com/p/cost-curve-fight-club-kicks-off-now-input-needed 2025-04-15 https://costcurve.beehiiv.com/p/magnificant-seven-another-ira-lawsuit-one-bi 2025-04-15 https://costcurve.beehiiv.com/p/merck-gets-big-approval-offers-lot-launchpricing-transparency 2025-04-15 https://costcurve.beehiiv.com/p/tariff-talk-wearying-but-necessary-i-guess 2025-05-22 https://costcurve.beehiiv.com/p/kennedy-not-good-on-vaccines-real-shaky-on-medicare-and-medicaid 2025-04-15 https://costcurve.beehiiv.com/p/feels-like-slow-news-week-not 2025-04-15 https://costcurve.beehiiv.com/p/trumprx-prices-are-attracting-attention-from-other-supply-chain-heavyweights 2025-10-10 https://costcurve.beehiiv.com/p/three-reasons-why-reporting-on-drug-pricing-details-still-makes-sense-for-pharma 2025-02-28 https://costcurve.beehiiv.com/p/new-op-eds-detail-the-anti-mfn-case-arguing-that-the-supply-chain-must-be-fixed-first-2aa7092ea39327 2025-06-26 https://costcurve.beehiiv.com/p/another-quarter-another-record-united-s-pbm-unit-records-nearly-40b-in-revenue-over-1-5b-in-profit 2025-10-29 https://costcurve.beehiiv.com/p/another-day-another-example-of-340b-abuse-featured-in-a-national-newspaper 2025-06-02 https://costcurve.beehiiv.com/p/drilling-into-last-week-s-legislative-action-how-the-new-law-impacts-rare-disease-development-2cd25e 2025-07-07 https://costcurve.beehiiv.com/p/will-ira-price-controls-sound-bad-actually-bad-az-comments-give-hint 2025-04-15 https://costcurve.beehiiv.com/p/the-uk-abandoned-biopharma-innovation-now-biopharma-is-abandoning-the-uk 2025-09-15 https://costcurve.beehiiv.com/p/introducing-the-trumprx-tracker-0278 2026-03-24 https://costcurve.beehiiv.com/p/huge-numbers-of-americans-are-adversely-impacted-by-prior-auth-requirements-new-poll-shows 2026-02-03 https://costcurve.beehiiv.com/p/pbmowned-mail-order-pharmacies-lot-expense-retail-pharmacies-wsj-says 2025-04-15 https://costcurve.beehiiv.com/p/well-it-really-happened-kennedy-is-the-secretary-of-hhs 2025-02-14 https://costcurve.beehiiv.com/p/man-hope-mark-cuban-clowns-new-employerfocused-pbm-campaign 2025-04-15 https://costcurve.beehiiv.com/p/winner-medicare-prescription-payment-plan-will-henceforth-known-m3p 2025-04-15 https://costcurve.beehiiv.com/p/new-evidence-shows-drug-prices-tend-to-go-down-each-year-that-ought-not-be-surprising-and-yet 2025-05-22 https://costcurve.beehiiv.com/p/optumrx-gets-business-selling-meds-stelara-humira-copycats-getting-sweetheart-formulary-placement 2025-04-15 https://costcurve.beehiiv.com/p/not-deluge-consumerfocused-smoothing-content 2025-04-15 https://costcurve.beehiiv.com/p/another-ira-decision-goes-pharma-musings-chevron 2025-04-15 https://costcurve.beehiiv.com/p/new-report-patent-life-reminder-pharma-isnt-explaining-ip 2025-04-15 https://costcurve.beehiiv.com/p/government-strikes-back-hhs-drops-first-briefs-litigation-ira 2025-04-15 https://costcurve.beehiiv.com/p/46brooklyn-report-makes-clear-pbm-pricing-medicare-gordian-knot 2025-04-15 https://costcurve.beehiiv.com/p/think-cbo-thinking-obesity 2025-04-15 https://costcurve.beehiiv.com/p/part-d-benefit-redesign-will-cost-drug-companies-billions-this-year-and-that-s-ok 2025-04-15 https://costcurve.beehiiv.com/p/there-has-been-a-small-deluge-of-mfn-news-over-the-past-24-hours-but-does-it-matter-727561d3c57e2a6b 2025-06-12 https://costcurve.beehiiv.com/p/story-2023-according-cost-curve-readers-iras-selected-drugs 2025-04-15 https://costcurve.beehiiv.com/p/oz-continues-to-press-for-mfn-codification-at-phrma-event 2026-02-18 https://costcurve.beehiiv.com/p/theres-340b-storm-brewing-jj-seeks-change-way-pays-stelara-xarelto 2025-04-15 https://costcurve.beehiiv.com/p/insurance-companies-are-on-the-hill-today-ready-to-point-fingers-and-make-concessions 2026-01-22 https://costcurve.beehiiv.com/p/government-position-copay-accumulators-softening 2025-04-15 https://costcurve.beehiiv.com/p/a-few-words-on-why-i-suspect-that-there-isn-t-a-secret-trump-agenda-on-medicare-negotiations-yet 2025-03-10 https://costcurve.beehiiv.com/p/mfn-comes-roaring-back-as-trump-sends-letters-pushing-17-companies-to-offer-mfn-prices-8ed5d1dc02863 2025-08-01 https://costcurve.beehiiv.com/p/the-current-state-of-play-on-mfn-skepticism-on-administrative-execution-attention-around-congression 2025-05-27 https://costcurve.beehiiv.com/p/redletter-day-geekybutimportant-research-reports 2025-04-15 https://costcurve.beehiiv.com/p/empty-offices-full-coffers-a-journalistic-expose-examines-how-pbms-use-group-purchasing-organization 2026-01-07 https://costcurve.beehiiv.com/p/lots-lots-new-data-unfathomably-big-340b-getting 2025-04-15 https://costcurve.beehiiv.com/p/and-we-re-off-the-next-15-drugs-up-for-medicare-negotiations-have-been-announced 2025-04-15 https://costcurve.beehiiv.com/p/bms-2023-pricing-numbers-yeah-net-prices-fell 2025-04-15 https://costcurve.beehiiv.com/p/trumprx-launch-pushed-back-though-questions-persist-around-the-reason-for-the-holdup 2026-01-30 https://costcurve.beehiiv.com/p/what-yesterday-s-rfk-jr-hearing-did-and-did-not-illuminate 2025-09-05 https://costcurve.beehiiv.com/p/catch-quick-merckira-lawsuit 2025-04-15 https://costcurve.beehiiv.com/p/data-says-drug-prices-falling-media-coverage-says-otherwise-sigh 2025-04-15 https://costcurve.beehiiv.com/p/putting-lilly-and-novo-s-white-house-obesity-agreements-under-the-microscope 2025-11-07 https://costcurve.beehiiv.com/p/votes-tallied-curve-readers-say-big-cms-reveal-will-come-week-aug-19 2025-04-15 https://costcurve.beehiiv.com/p/new-kff-poll-drug-prices-undermines-faith-fellow-americans 2025-04-15 https://costcurve.beehiiv.com/p/npc-study-highlights-employer-blind-spots-rebates-pbms-benefit-consultants 2025-04-15 https://costcurve.beehiiv.com/p/past-panics-newmed-introductions-overblown-lessons-todays-panics 2025-04-15 https://costcurve.beehiiv.com/p/governments-approach-ira-lawsuits-becoming-clear 2025-04-15 https://costcurve.beehiiv.com/p/changing-guard-icer 2025-04-15 https://costcurve.beehiiv.com/p/readers-respond-on-how-tariffs-will-hit-pharma-and-pharmacy 2025-05-22 https://costcurve.beehiiv.com/p/biocentury-goes-deep-arnold-ventures-shaped-ira-going-next 2025-04-15 https://costcurve.beehiiv.com/p/on-a-busy-day-for-pricing-and-policy-news-here-are-the-top-10-stories 2026-03-30 https://costcurve.beehiiv.com/p/apex-340b-decision-means-that-the-government-is-on-the-spot-to-determine-the-fate-of-the-rebate-mode 2025-05-16 https://costcurve.beehiiv.com/p/oz-urges-pbms-to-do-away-with-rebates-lest-the-government-decide-to-intervene-88861f3d38977d0e 2025-06-25 https://costcurve.beehiiv.com/p/j-j-hits-back-on-340b-as-the-rebate-model-heads-to-federal-court 2025-04-15 https://costcurve.beehiiv.com/p/coming-soon-masterclass-using-utilization-management-obesity-meds 2025-04-15 https://costcurve.beehiiv.com/p/novo-s-latest-move-shines-more-light-on-how-it-s-structuring-pharm-to-table 2025-06-02 https://costcurve.beehiiv.com/p/340bonanza-more-on-the-mn-report-sanofi-s-gambit-and-hrsa-goes-after-providers 2025-04-15 https://costcurve.beehiiv.com/p/advice-for-2025-survey-now-live 2025-04-15 https://costcurve.beehiiv.com/p/wall-street-amping-pressure-drugmakers-stop-studies-early-irarelated-reasons 2025-04-15 https://costcurve.beehiiv.com/p/government-watchdog-alleges-cvs-caremark-overcharged-a-federal-employee-health-plan-by-more-than-600 2026-03-23 https://costcurve.beehiiv.com/p/cnbc-says-ira-negotiations-will-intense-heres-wont 2025-04-15 https://costcurve.beehiiv.com/p/bms-and-pfizer-plant-the-seed-for-an-eliquis-pharm-to-table-program-5116cf50939d6ba5 2025-07-17 https://costcurve.beehiiv.com/p/two-companies-enter-iralawsuit-fray 2025-04-15 https://costcurve.beehiiv.com/p/breaking-down-the-pharma-price-control-math-in-harris-home-care-proposal 2025-04-15 https://costcurve.beehiiv.com/p/policy-talk-muted-jpm24-doesnt-mean-impacts-arent-felt 2025-04-15 https://costcurve.beehiiv.com/p/empire-strikes-back-first-government-brief-az-ira-case-hit-last-night 2025-04-15 https://costcurve.beehiiv.com/p/regulating-dtc-is-all-the-rage-suddenly-but-it-turns-out-that-americans-do-want-to-hear-from-brands 2025-06-16 https://costcurve.beehiiv.com/p/goodrx-proves-value-goodpr 2025-04-15 https://costcurve.beehiiv.com/p/pbm-reform-probably-mostly-dead-2024-will-come-back-harder-2025 2025-04-15 https://costcurve.beehiiv.com/p/venn-visualize-forces-pbm-reform 2025-04-15 https://costcurve.beehiiv.com/p/79-highly-rebated-drugs-medicare-patients-paying-health-plans 2025-04-15 https://costcurve.beehiiv.com/p/still-catching-mustread-stat-piece-value-thinking-insulin 2025-04-15 https://costcurve.beehiiv.com/p/lilly-supercharges-the-pharm-to-conference-table-ecosystem-partnering-with-18-companies-to-bring-low 2026-03-05 https://costcurve.beehiiv.com/p/icer-finalizes-approach-value-assessment-industry-remains-dissatisfied 2025-04-15 https://costcurve.beehiiv.com/p/looking-around-the-corner-at-a-report-from-minnesota-that-may-illuminate-the-340b-program 2025-04-15 https://costcurve.beehiiv.com/p/today-s-the-day-lilly-and-novo-are-set-for-a-white-house-deal-on-obesity 2025-11-06 https://costcurve.beehiiv.com/p/biden-push-around-insulin-raises-worthwhile-question-solved-insulin-issue 2025-04-15 https://costcurve.beehiiv.com/p/obesity-storylines-getting-played-3-pieces-still-worth-time 2025-04-15 https://costcurve.beehiiv.com/p/putting-all-of-the-pharm-to-table-resources-in-one-place 2025-10-03 https://costcurve.beehiiv.com/p/more-details-on-how-the-administration-s-new-look-340b-program-might-operate 2025-04-22 https://costcurve.beehiiv.com/p/keep-eye-pbm-angle-wouldbe-cignahumana-merger 2025-04-15 https://costcurve.beehiiv.com/p/apex-most-favored-nation-is-floated-by-the-white-house-to-a-frosty-reception-from-congress-09bc0d339 2025-05-16 https://costcurve.beehiiv.com/p/judge-pauses-trump-effort-to-massively-role-back-funding-for-nih-grantees 2025-02-22 https://costcurve.beehiiv.com/p/incomplete-list-highprofile-roy-news-im-waiting 2025-04-15 https://costcurve.beehiiv.com/p/thinking-earnings-including-jnjs-take-ira 2025-04-15 https://costcurve.beehiiv.com/p/does-rfk-jr-support-march-in-rights-thinking-through-the-either-ors 2025-04-15 https://costcurve.beehiiv.com/p/action-on-ira-lawsuits-appeals-court-rejects-the-u-s-chamber-effort-on-technical-grounds-1a12d336d78 2025-08-07 https://costcurve.beehiiv.com/p/here-s-a-thought-experiment-what-would-happen-if-340b-profits-were-directed-to-retiring-medical-debt 2025-02-19 https://costcurve.beehiiv.com/p/icers-leaky-approach-value-assessment 2025-04-15 https://costcurve.beehiiv.com/p/it-s-drug-price-transparency-season-but-disclosures-may-be-on-the-wane 2025-02-25 https://costcurve.beehiiv.com/p/much-pdab-today 2025-04-15 https://costcurve.beehiiv.com/p/more-on-the-tax-cuts-and-medicaid-cuts-bill-including-an-apex-analysis-of-a-biotech-boosting-r-d-tax 2025-07-08 https://costcurve.beehiiv.com/p/detailing-math-behind-impact-ira-price-controls-patients 2025-04-15 https://costcurve.beehiiv.com/p/why-a-new-drug-just-entered-the-market-with-a-list-price-one-tenth-of-its-rival 2025-11-19 https://costcurve.beehiiv.com/p/all-eyes-are-on-mfn-but-action-and-specifics-remain-elusive-0b85f233581c0b97 2026-01-15 https://costcurve.beehiiv.com/p/industry-patient-groups-agree-time-drive-attention-smoothing 2025-04-15 https://costcurve.beehiiv.com/p/abbvies-humira-numbers-show-well-company-can-play-rebate-game 2025-04-15 https://costcurve.beehiiv.com/p/a-skyrocketing-number-of-big-city-hospitals-are-qualifying-as-administratively-rural-8f33b5f9406193a 2025-08-05 https://costcurve.beehiiv.com/p/apex-same-arguments-same-examples-where-trump-and-bernie-are-lined-up-on-international-prices-21a516 2025-05-16 https://costcurve.beehiiv.com/p/thursday-day-ira-price-control-announcement-per-politico 2025-04-15 https://costcurve.beehiiv.com/p/a-clip-n-save-guide-to-the-next-15-medicines-up-for-medicare-price-controls 2025-04-15 https://costcurve.beehiiv.com/p/pbm-bills-advance-congress-big-question-whats-next 2025-04-15 https://costcurve.beehiiv.com/p/apex-special-edition-all-things-price-and-oncology-29a45f4e8053809f 2025-06-05 https://costcurve.beehiiv.com/p/pbm-market-power-definitely-concentrated-ama-report-finds 2025-04-15 https://costcurve.beehiiv.com/p/pfizer-cut-the-price-of-certain-forms-of-ibrance-its-blockbuster-breast-cancer-med 2026-02-11 https://costcurve.beehiiv.com/p/new-phrma-research-defines-postapproval-rd-risk 2025-04-15 https://costcurve.beehiiv.com/p/reflecting-governmentcompany-ira-interactions-light-wsjs-reporting 2025-04-15 https://costcurve.beehiiv.com/p/think-size-price-controls-cms-may-impose 2025-04-15 https://costcurve.beehiiv.com/p/can-spending-on-trumprx-be-applied-to-insurance-deductibles-it-s-complicated 2026-02-10 https://costcurve.beehiiv.com/p/judge-strikes-blow-copay-accumulators 2025-04-15 https://costcurve.beehiiv.com/p/the-four-elements-of-the-pfizer-trump-deal-to-keep-an-eye-on 2025-10-01 https://costcurve.beehiiv.com/p/new-analysis-questions-iras-orphandrug-exemption-without-talking-tradeoffs 2025-04-15 https://costcurve.beehiiv.com/p/new-iqvia-data-makes-clear-drug-prices-theyre-going 2025-04-15 https://costcurve.beehiiv.com/p/gsk-and-amgen-add-select-meds-to-trumprx-offering-new-angles-on-the-pharm-to-table-future 2026-03-16 https://costcurve.beehiiv.com/p/gallup-data-underscores-far-underwater-pharmas-rep-especially-gop 2025-04-15 https://costcurve.beehiiv.com/p/pre-holiday-wrap-a-couple-new-drugs-some-health-policy-chatter-and-more-analyses-putting-mfps-in-con 2025-04-15 https://costcurve.beehiiv.com/p/challenge-autumn-filtering-badfaith-policy-arguments 2025-04-15 https://costcurve.beehiiv.com/p/three-340b-narratives-to-watch-state-medicaid-vs-340b-providers-the-impact-of-340b-on-smaller-clinic 2026-03-11 https://costcurve.beehiiv.com/p/three-quick-ones-today 2025-04-15 https://costcurve.beehiiv.com/p/the-white-house-wants-to-stick-340b-within-cms-will-hijinx-ensue 2025-05-22 https://costcurve.beehiiv.com/p/ira-might-raise-patient-oops-millions-heres-numbers-work 2025-04-15 https://costcurve.beehiiv.com/p/ira-lawsuits-get-deadlines 2025-04-15 https://costcurve.beehiiv.com/p/questioning-value-obesity-meds-distracts-conversation 2025-04-15 https://costcurve.beehiiv.com/p/marylands-pdab-frustrated-slow-pace-work-rest-us-not-surprised 2025-04-15 https://costcurve.beehiiv.com/p/a-most-favored-nation-approach-in-medicaid-would-have-mammoth-unintended-consequences-7301e97b60ca3c 2025-05-16 https://costcurve.beehiiv.com/p/a-new-jama-paper-finds-hospitals-aren-t-sharing-the-savings-from-cancer-biosimilars 2026-03-12 https://costcurve.beehiiv.com/p/bernie-suggests-that-pbms-wouldn-t-penalize-novo-for-price-cuts-the-reality-is-more-complicated 2025-04-15 https://costcurve.beehiiv.com/p/vanda-s-new-schizophrenia-drug-offers-the-company-a-way-out-of-medicaid-inflation-penalties 2026-03-27 https://costcurve.beehiiv.com/p/where-pharma-came-down-on-the-ira-during-3q24-earnings-calls 2025-04-15 https://costcurve.beehiiv.com/p/340b-used-easy-ignore-no-longer 2025-04-15 https://costcurve.beehiiv.com/p/examining-the-latest-launch-price-ionis-dawnzera-dfc6487acaa6f512 2025-08-22 https://costcurve.beehiiv.com/p/the-number-of-companies-set-to-make-mfn-announcements-today-is-up-to-at-least-six 2025-12-19 https://costcurve.beehiiv.com/p/ozempic-will-be-up-for-ira-negotiation-here-are-the-only-four-storylines-you-ll-see 2025-04-15 https://costcurve.beehiiv.com/p/boehringer-ingelheim-s-appeal-to-overturn-the-ira-on-constitutional-grounds-is-dismissed-1dab0c56a68 2025-08-08 https://costcurve.beehiiv.com/p/the-newest-340b-tempest-raises-four-questions-that-should-be-asked-but-aren-t 2025-04-15 https://costcurve.beehiiv.com/p/lilly-expands-its-pharm-to-table-offering-promotes-a-lower-price-for-consistent-use-fd0e4fb51c7d8cb1 2025-06-17 https://costcurve.beehiiv.com/p/avalere-analysis-shows-long-expensive-road-cv-meds-postira 2025-04-15 https://costcurve.beehiiv.com/p/trump-makes-a-deal-with-pfizer-on-medicaid-and-announces-a-direct-to-patient-website 2025-09-30 https://costcurve.beehiiv.com/p/iqvia-makes-clear-blame-fall-broken-humira-biosims-market 2025-04-15 https://costcurve.beehiiv.com/p/quick-hits-everything-alopecia-340b-elon-musk 2025-04-15 https://costcurve.beehiiv.com/p/hrsa-annual-340b-data-release-is-out-and-the-numbers-are-real-real-big 2025-04-15 https://costcurve.beehiiv.com/p/digging-even-deeper-into-the-treasure-trove-of-the-cassidy-report-on-340b 2025-05-20 https://costcurve.beehiiv.com/p/letting-a-million-flowers-bloom-the-implications-of-an-excellent-revision-to-the-value-flower 2025-04-15 https://costcurve.beehiiv.com/p/will-the-price-disclosure-for-vertex-s-journavx-set-a-new-standard-for-transparency 2025-04-15 https://costcurve.beehiiv.com/p/ira-harmless-narrative-misses-mark 2025-04-15 https://costcurve.beehiiv.com/p/the-depth-of-anger-around-health-care-has-been-laid-bare-cigna-seems-to-recognize-that-danger 2025-04-15 https://costcurve.beehiiv.com/p/pharm-to-table-commentary-on-earnings-calls-so-hot-right-now-af050edf3c71e621 2025-08-06 https://costcurve.beehiiv.com/p/we-re-back-at-it-here-are-the-four-key-holiday-storylines-to-get-you-caught-up 2026-01-05 https://costcurve.beehiiv.com/p/the-reconciliation-bill-passes-the-senate-orphan-ira-fix-included-26683155e55be30 2025-07-02 https://costcurve.beehiiv.com/p/this-year-jan-1-price-drops-might-be-as-interesting-as-the-price-hikes 2025-04-15 https://costcurve.beehiiv.com/p/was-the-white-house-s-attack-on-dtc-advertising-fueled-by-robots 2025-09-12 https://costcurve.beehiiv.com/p/cignas-evernorth-unit-will-sell-humira-biosimilar-quallent-drug-company-accredo-pharmacy 2025-04-15 https://costcurve.beehiiv.com/p/the-ira-is-disincentivizing-the-development-of-higher-value-medicines-health-affairs-study-says 2025-04-15 https://costcurve.beehiiv.com/p/pharma-is-investing-in-innovation-at-a-record-rate-and-other-trends-from-an-awesome-new-iqvia-report 2025-06-02 https://costcurve.beehiiv.com/p/coming-soon-to-a-pharmacy-near-you-big-list-price-cuts-on-blockbuster-drugs 2025-11-12 https://costcurve.beehiiv.com/p/a-brief-reminder-medicare-negotiations-alone-don-t-really-save-money-for-seniors 2025-04-15 https://costcurve.beehiiv.com/p/apex-trump-s-mfn-executive-order-underwhelms-just-about-everyone-918609eb1b0bfcf2 2025-05-16 https://costcurve.beehiiv.com/p/three-new-research-pieces-boost-understanding-pharma-industry-nuances 2025-04-15 https://costcurve.beehiiv.com/p/new-study-cost-diabetes-drug-production-shouldnt-matter-us-anyway 2025-04-15 https://costcurve.beehiiv.com/p/wegovy-comes-big-outcomes-study-adding-fuel-reimbursement-fire 2025-04-15 https://costcurve.beehiiv.com/p/cms-done-hearing-patients-ira-listen 2025-04-15 https://costcurve.beehiiv.com/p/ten-thoughts-yesterdays-big-ira-pricesetting-announcement 2025-04-15 https://costcurve.beehiiv.com/p/kff-ira-survey-shows-just-little-average-americans-tracking-health-policy 2025-04-15 https://costcurve.beehiiv.com/p/new-data-underscores-that-access-barriers-for-patients-are-high-and-getting-higher 2025-04-15 https://costcurve.beehiiv.com/p/how-to-think-and-talk-about-value-in-the-rfk-jr-era-part-two 2025-04-15 https://costcurve.beehiiv.com/p/the-three-generally-ignored-forces-driving-the-pharm-to-table-trend-89a1ee73dee87faa 2025-08-19 https://costcurve.beehiiv.com/p/latearriving-thoughts-sotu-way-heat-light-drug-pricing 2025-04-15 https://costcurve.beehiiv.com/p/the-second-day-reaction-to-the-dtc-letters-oprah-gets-a-look-pharma-gets-targeted-and-fda-s-capacity 2025-09-17 https://costcurve.beehiiv.com/p/20minute-antipharma-rant-probably-need-see 2025-06-10 https://costcurve.beehiiv.com/p/a-congressional-examination-of-pharm-to-table-deals-offers-zero-surprises-a2585243d3c50bad 2025-07-18 https://costcurve.beehiiv.com/p/people-are-getting-real-nervous-about-premium-increases-abfcb024f6df7b47 2025-08-27 https://costcurve.beehiiv.com/p/tariffs-and-mfn-dominate-the-headlines-but-details-remain-scant 2025-09-26 https://costcurve.beehiiv.com/p/lilly-takes-a-first-step-in-rebalancing-u-s-and-international-prices-887692610a19a5a5 2025-08-15 https://costcurve.beehiiv.com/p/it-s-conference-szn-here-s-where-cost-curve-readers-are-headed 2025-03-12 https://costcurve.beehiiv.com/p/340b-is-driving-up-employer-costs-by-billions-state-by-state-iqvia-assessment-shows 2025-04-15 https://costcurve.beehiiv.com/p/insulin-access-mostly-solved-issue-thoughts-happened 2025-04-15 https://costcurve.beehiiv.com/p/are-medicines-on-trumprx-seeing-a-boost-in-prescriptions-the-data-suggests-the-answer-is-mostly-no 2026-03-06 https://costcurve.beehiiv.com/p/the-wall-street-journal-is-asking-tough-questions-about-connections-between-the-white-house-and-blin 2025-10-08 https://costcurve.beehiiv.com/p/1600-medicines-development-cancer-proving-incentives-matter 2025-04-15 https://costcurve.beehiiv.com/p/lillys-drugprice-reporting-shows-just-far-insulin-prices-fallen 2025-04-15 https://costcurve.beehiiv.com/p/the-fda-assault-on-dtc-advertising-is-targeting-a-lot-more-than-just-tv-ads 2025-09-19 https://costcurve.beehiiv.com/p/beware-pbms-bearing-obesity-drug-data 2025-04-15 https://costcurve.beehiiv.com/p/colorado-pdab-renders-split-decision-affordability-enbrel-genvoya 2025-04-15 https://costcurve.beehiiv.com/p/the-white-house-view-on-pharm-to-table-it-s-not-the-solution-in-itself-a31b814adbdfb123 2025-08-14 https://costcurve.beehiiv.com/p/ftcs-new-report-whomps-pbms-will-leave-mark 2025-04-15 https://costcurve.beehiiv.com/p/wants-finish-shkrelis-noble-drugpricing-scheme 2025-04-15 https://costcurve.beehiiv.com/p/unitedhealth-group-made-55-billion-last-quarter-even-though-maybe-insurance-keeps-getting-worse 2025-04-15 https://costcurve.beehiiv.com/p/health-insurance-execs-create-heat-not-light-in-house-testimony 2026-01-23 https://costcurve.beehiiv.com/p/it-s-probably-a-good-day-to-rake-leaves 2025-04-15 https://costcurve.beehiiv.com/p/astrazeneca-absolutely-considering-pharm-to-table-4ccdd97ea4e2429b 2025-07-30 https://costcurve.beehiiv.com/p/novartis-makes-nine-yup-another-ira-lawsuit 2025-04-15 https://costcurve.beehiiv.com/p/the-nyt-refutes-trumprx-s-world-s-lowest-prices-claim-but-the-analysis-misses-key-context 2026-03-18 https://costcurve.beehiiv.com/p/thoughts-medicare-price-controls-folks-know-score 2025-04-15 https://costcurve.beehiiv.com/p/happy-festivus-cost-curve-readers-have-some-grievances-they-d-like-to-air 2025-12-23 https://costcurve.beehiiv.com/p/pricingtransparency-data-gsk-novo-gives-perspective-business-pharma 2025-04-15 https://costcurve.beehiiv.com/p/measuring-iras-impact-innovation 2025-04-15 https://costcurve.beehiiv.com/p/christmas-comes-early-for-the-wonks-with-cms-demonstrations-and-mfn-announcements 2025-12-22 https://costcurve.beehiiv.com/p/lilly-says-lists-prices-rose-3-8-last-year-though-the-net-prices-tell-a-more-fascinating-story-f1728 2025-06-09 https://costcurve.beehiiv.com/p/icer-s-unsupported-price-increases-report-misses-the-mark-again 2025-04-15 https://costcurve.beehiiv.com/p/more-on-the-biggest-story-of-fall-2025-the-growth-in-health-care-spending 2025-09-04 https://costcurve.beehiiv.com/p/340b-gets-attention-in-the-senate-but-the-prospects-for-action-remain-cloudy 2025-10-24 https://costcurve.beehiiv.com/p/vaccine-politics-and-policy-have-gone-off-the-rails-let-s-hope-reimbursement-stays-on-track-0d81cbb2 2025-06-13 https://costcurve.beehiiv.com/p/sales-at-340b-prices-continue-to-skyrocket-jumping-to-more-than-81-billion-even-as-questions-remain 2025-12-12 https://costcurve.beehiiv.com/p/states-couldnt-keep-fastchanging-insulin-market-health-affairs-papers-suggest 2025-04-15 https://costcurve.beehiiv.com/p/remaining-leqembi-question-will-sales-gargantuan-merely-big 2025-04-15 https://costcurve.beehiiv.com/p/five-takeaways-about-the-wild-and-evolving-cash-pay-market-for-obesity-meds 2026-02-05 https://costcurve.beehiiv.com/p/will-know-hard-bargain-cms-drove-ira-price-controls 2025-04-15 https://costcurve.beehiiv.com/p/amgen-to-offer-repatha-directly-to-patients-for-less-than-other-countries-are-paying 2025-10-07 https://costcurve.beehiiv.com/p/nejm-study-adds-overwhelming-evidence-hospital-markups-need-340b-reform 2025-04-15 https://costcurve.beehiiv.com/p/more-signs-the-trump-administration-isn-t-going-to-use-nih-to-push-for-drug-pricing-action 2025-03-06 https://costcurve.beehiiv.com/p/revised-predictions-next-15-drugs-face-ira-price-controls 2025-04-15 https://costcurve.beehiiv.com/p/trumprx-is-live-it-s-underwhelming 2026-02-06 https://costcurve.beehiiv.com/p/health-spending-is-only-headed-in-one-direction-up-and-employers-are-blaming-the-meds-a21653a1b328bc 2025-08-20 https://costcurve.beehiiv.com/p/cms-announces-details-on-its-plan-to-bring-obesity-meds-into-medicare 2026-03-10 https://costcurve.beehiiv.com/p/how-to-think-and-talk-about-value-in-the-rfk-jr-era-part-one 2025-04-15 https://costcurve.beehiiv.com/p/i-m-not-sure-where-to-begin-today-health-costs-340b-dtc-ads-patent-shenanigans 2025-09-10 https://costcurve.beehiiv.com/p/pbm-reform-house-officially-thing-now 2025-04-15 https://costcurve.beehiiv.com/p/pbm-reform-is-signed-into-law-europe-deals-with-mfn-realities-and-a-timely-plea-for-mppp-awareness 2026-02-04 https://costcurve.beehiiv.com/p/another-day-another-set-questions-obesitymed-coverage 2025-04-15 https://costcurve.beehiiv.com/p/not-mark-cuban-never 2025-04-15 https://costcurve.beehiiv.com/p/tuesday-apparently-day-cms-releases-first-10-meds-price-controls 2025-04-15 https://costcurve.beehiiv.com/p/hospitals-allege-340b-collusion-in-a-context-free-letter-to-the-doj-and-ftc 2025-09-09 https://costcurve.beehiiv.com/p/great-wsj-story-looks-false-promise-drugs-two-prices 2025-04-15 https://costcurve.beehiiv.com/p/arnold-ventures-2024-grant-awards-are-now-public-here-s-what-those-dollars-say-about-the-group-s-goa 2025-12-16 https://costcurve.beehiiv.com/p/price-transparency-reports-are-on-the-decline-here-are-three-theories-why-0126 2025-02-27 https://costcurve.beehiiv.com/p/reactions-to-friday-s-340b-ruling-roll-in-ba64ce20c85efe6b 2025-05-19 https://costcurve.beehiiv.com/p/a-parade-of-pharma-execs-have-been-asked-about-mfn-this-week-and-the-commentary-is-unintentionally-r 2025-06-11 https://costcurve.beehiiv.com/p/the-trump-administration-is-selling-mfn-codification-but-no-one-is-buying 2026-02-26 https://costcurve.beehiiv.com/p/stelara-biosimilars-begin-to-launch-showcasing-again-the-weirdness-of-a-system-that-doesn-t-reward-l 2025-02-18 https://costcurve.beehiiv.com/p/nyts-offthemark-explainer-making-smart-conversations-drug-pricing-harder 2025-04-15 https://costcurve.beehiiv.com/p/it-s-nye-which-means-champagne-and-low-context-articles-about-jan-1-drug-price-hikes 2025-04-15 https://costcurve.beehiiv.com/p/so-much-340b-scotus-weighs-in-a-georgia-system-nets-700m-in-profit-and-more 2025-04-15 https://costcurve.beehiiv.com/p/looking-bit-sunlight-illuminate-pdab-efforts-colorado-maryland 2025-04-15 https://costcurve.beehiiv.com/p/arnold-ventures-is-driving-health-policy-discourse-in-the-u-s-here-s-how-they-re-spending-their-mone 2025-04-15 https://costcurve.beehiiv.com/p/the-impact-of-mfn-especially-overseas-remains-cloudy 2026-03-25 https://costcurve.beehiiv.com/p/injected-versions-of-cancer-meds-make-life-easier-for-patients-and-drive-savings-for-clinicians-ther 2025-09-23 https://costcurve.beehiiv.com/p/new-math-hep-c-drugs-suggests-medicines-may-way-better-deal-thought 2025-04-15 https://costcurve.beehiiv.com/p/the-government-might-want-amazon-and-walmart-involved-in-its-direct-to-consumer-push-broadening-what 2025-06-30 https://costcurve.beehiiv.com/p/great-overview-pdab-process-underscores-flaws-state-price-controls 2025-04-15 https://costcurve.beehiiv.com/p/ten-quick-thoughts-cms-announcement-governmentset-prices-medicare 2025-04-15 https://costcurve.beehiiv.com/p/new-post-718d 2025-04-15 https://costcurve.beehiiv.com/p/working-strange-math-weird-consequences-ira-inflation-penalties 2025-04-15 https://costcurve.beehiiv.com/p/icer-s-report-on-launch-pricing-falls-short-by-emphasizing-questionable-price-data-rather-than-acces 2025-10-23 https://costcurve.beehiiv.com/p/looking-2022-drug-approvals-received-attention-around-pricing 2025-04-15 https://costcurve.beehiiv.com/p/icer-is-tackling-launch-pricing-i-m-wishing-them-luck-they-ll-need-it 2025-04-15 https://costcurve.beehiiv.com/p/connecting-dots-whether-tagrisso-will-targeted-price-controls 2025-04-15 https://costcurve.beehiiv.com/p/californias-efforts-deliver-cheap-meds-citizens-good-noble-not-drugprice-revolution 2025-04-15 https://costcurve.beehiiv.com/p/implementation-of-the-medicare-prescription-payment-plan-appears-to-be-failing 2025-04-15 https://costcurve.beehiiv.com/p/list-wouldbe-ira-targets-list-ira-legal-deadlines 2025-04-15 https://costcurve.beehiiv.com/p/tough-lessons-generic-truvada-will-retaught-context-ira 2025-04-15 https://costcurve.beehiiv.com/p/a-must-read-assessment-of-340b-legislation-encourages-policymakers-to-think-hard-about-tradeoffs-ffb 2025-05-28 https://costcurve.beehiiv.com/p/ira-irony-oral-cancer-meds 2025-04-15 https://costcurve.beehiiv.com/p/the-u-k-will-make-efforts-to-boost-drug-prices-in-return-for-the-elimination-of-u-s-tariffs 2025-12-02 https://costcurve.beehiiv.com/p/earnings-calls-are-chockablock-with-policy-talk-this-month-mfn-pbms-340b-and-more-6e64 2025-05-20 https://costcurve.beehiiv.com/p/what-happens-to-prices-if-when-pharma-gets-hit-with-tariffs-it-s-not-quite-clear 2025-05-22 https://costcurve.beehiiv.com/p/the-power-and-limits-of-digital-age-advocacy 2025-04-15 https://costcurve.beehiiv.com/p/cms-drops-first-ten-meds-price-controlled-including-surprises 2025-04-15 https://costcurve.beehiiv.com/p/special-curve-lets-tackle-cms-pricecontrol-guidance 2025-04-15 https://costcurve.beehiiv.com/p/upon-review-maybe-cms-webpage-mppp-kind-mess 2025-04-15 https://costcurve.beehiiv.com/p/jnj-s-industry-defining-price-transparency-report-is-out 2025-04-15 https://costcurve.beehiiv.com/p/apex-obesity-grabs-the-headlines-looking-at-a-novo-formulary-win-and-a-new-paper-on-budget-impact-96 2025-05-16 https://costcurve.beehiiv.com/p/drugpricing-narrative-picture-thats-worth-way-thousand-words 2025-04-15 https://costcurve.beehiiv.com/p/bidenbernie-oped-underscores-lack-seriousness-attacks-drug-pricing 2025-04-15 https://costcurve.beehiiv.com/p/comments-are-due-today-on-the-administration-s-proposed-pilot-programs-to-bring-mfn-into-medicare 2026-02-23 https://costcurve.beehiiv.com/p/pictures-are-worth-a-thousand-words-so-here-are-3-000-words-on-ira-um-and-formulary-design 2025-04-15 https://costcurve.beehiiv.com/p/unpacking-underlying-economics-ira-innovation 2025-04-15 https://costcurve.beehiiv.com/p/the-tax-medicaid-bill-puts-rural-hospitals-on-the-brink-what-does-that-mean-for-340b-2b87cf539364c1e 2025-07-10 https://costcurve.beehiiv.com/p/industrys-day-court-ira-went-little-sideways-dont-find-argument-compelling 2025-04-15 https://costcurve.beehiiv.com/p/big-pharma-companies-won-concessions-via-dealmaking-with-trump-but-what-happens-to-everyone-else 2026-02-12 https://costcurve.beehiiv.com/p/hospital-markups-prescription-drugs-really-pretty-unbelievable 2025-04-15 https://costcurve.beehiiv.com/p/the-administration-seems-to-be-moving-the-mfn-push-from-medicaid-to-medicare-buckle-up-66e72321f5b23 2025-05-16 https://costcurve.beehiiv.com/p/a-barron-s-piece-lays-bare-the-pbm-opioid-connection 2025-04-15 https://costcurve.beehiiv.com/p/10-thoughts-on-trump-s-drug-pricing-executive-order 2025-04-16 https://costcurve.beehiiv.com/p/the-presidential-election-results-might-be-clear-but-the-health-policy-implications-are-not 2025-04-15 https://costcurve.beehiiv.com/p/ira-legal-crosshairs-redux 2025-04-15 https://costcurve.beehiiv.com/p/pbm-reform-back-front-burner 2025-04-15 https://costcurve.beehiiv.com/p/dealing-deluge-morning 2025-04-15 https://costcurve.beehiiv.com/p/a-roundup-of-how-pharma-companies-responded-to-the-medicare-drug-negotiation-announcement-last-week 2025-04-15